Aarti Drugs Limited — Call Transcript 2024

Jan 19, 2024

==> picture [512 x 106] intentionally omitted <==

Ref: ADL/SE/2023-24/107 January 19, 2024

To, To, Listing/ Compliance Department Listing/ Compliance Department BSE Limited National Stock Exchange of India Phiroze Jeejeebhoy Towers, Limited, Dalal Street, “Exchange Plaza”, Bandra - Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400051

BSE CODE – 524348

NSE SYMBOL: AARTIDRUGS

Dear Sir/Madam,

Ref : Regulation 30 of SEBI (LODR) Regulations, 2015 Sub: Intimation of Earning Conference Call

This is to inform you that Quarterly Earning Conference Call for the Investors and Analysts has been scheduled on Thursday, January 25, 2024 at 12:00 Noon IST to discuss the Company’s financial performance for the Quarter and nine months ended December 31, 2023. Please find attached herewith invitation for the same.

Kindly take the same on record.

Thanking you,

Yours faithfully,

FOR AARTI DRUGS LIMITED

RUSHIKESH VIVEK Digitally signed by RUSHIKESH VIVEK DEOLE DEOLE Date: 2024.01.19 18:12:16 +05'30' RUSHIKESH DEOLE COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M.No.: F12932

==> picture [468 x 29] intentionally omitted <==

==> picture [287 x 50] intentionally omitted <==

Aarti Drugs Limited Q3 & 9M FY24 Earnings Conference Call

DATE & TIME 25[th] January 2024 (Thursday) 12:00 noon, IST (HK/Singapore 2:30 pm, UK 6:30 am, USA 1:30 am EST)

PARTICIPANTS

Mr. Harshit Savla – Jt. Managing Director Mr. Harit Shah – Whole time Director Mr. Adhish Patil – Chief Finance Officer & Chief Operating Officer Mr. Vishwa Savla – Managing Director, Pinnacle Life Science Private Limited

PRE REGISTRATION LINK – CLICK HERE

CONFERENCE DIAL IN DETAILS

INDIA	+91 22 6280 1309 / +91 22 7115 8210
UNITED STATES	1 866 746 2133
UNITED KINGDOM	0 808 101 1573
SINGAPORE	800 101 2045
HONG KONG	800 964 448

RSVP:

Strategic Growth Advisors Pvt. Ltd.

Mr. Deven Dhruva / Mr. Harsh Shah Contact: +91 98333 73300 / +91 97689 74808